Carlo FRANCHINI

Prof. Carlo FRANCHINI

orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Domenico IacopettaDomenico Iacopetta
Domenico Iacopetta
Jessica CeramellaJessica Ceramella
Jessica Ceramella
ACAlessia Catalano
Alessia Catalano
Carmela SaturninoCarmela Saturnino
Carmela Saturnino
MBMaria Grazia Bonomo
Maria Grazia Bonomo
Maria Stefania SinicropiMaria Stefania Sinicropi
Maria Stefania Sinicropi
Schiff bases, named after Hugo Schiff, are highly reactive organic compounds broadly used as pigments and dyes, catalysts, intermediates in organic synthesis, and polymer stabilizers. Lots of Schiff bases are described in the literature for various biological activities, including antimalarial, antibacterial, antifungal, anti-inflammatory, and antiviral. Schiff bases are also known for their ability to form complexes with several metals. Very often, complexes of Schiff bases with metals and Schiff bases alone have demonstrated interesting antitumor activity. Given the innumerable vastness of data regarding antitumor activity of all these compounds, we focused our attention on mono- and bis-Schiff bases alone as antitumor agents. We will highlight the most significant examples of compounds belonging to this class reported in the literature.

1 June 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ACAlessia Catalano
Alessia Catalano
ACAlessia Carocci
Alessia Carocci
IDIvana Defrenza
Ivana Defrenza
MMMarilena Muraglia
Marilena Muraglia
Antonio CarrieriAntonio Carrieri
Antonio Carrieri
CFCarlo FRANCHINI
Carlo FRANCHINI

25 September 2009 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
CFCarlo FRANCHINI
Carlo FRANCHINI
MMMarilena Muraglia
Marilena Muraglia
Filomena CorboFilomena Corbo
Filomena Corbo
MFMarco Antonio Florio
Marco Antonio Florio
AMAntonio Massa
Antonio Massa
CVCesare Vitali
Cesare Vitali

14 April 2010 in Endocrinology
Verified
Journal Article
Open access
PDF file
ECE. Cipolletta
E. Cipolletta
SMS. Monaco
S. Monaco
Angela Serena MaioneAngela Serena Maione
Angela Serena Maione
LVLaura Vitiello
Laura Vitiello
Pietro CampigliaPietro Campiglia
Pietro Campiglia
Maddalena IllarioMaddalena Illario
Maddalena Illario
Vascular smooth muscle cell (VSMC) proliferation contributes to vascular remodeling in atherosclerosis and hypertension. Calcium-dependent signaling through calcium/calmodulin-dependent kinase II (CaMKII) and ERK1/2 activation plays an important role in the regulation of VSMC proliferation by agents such as α-adrenergic receptor agonists. Nevertheless, how the CaMKII and ERK pathways interact in VSMCs has yet to be characterized. The aim of the present study was to clarify this interaction in response to α1-adrenergic receptor-mediated VSMC proliferation. We discovered that phenylephrine stimulation resulted in complex formation between CaMKII and ERK in a manner that facilitated phosphorylation of both protein kinases. To assess the effects of CaMKII/ERK association on VSMC proliferation, we inhibited endogenous CaMKII either pharmacologically or by adenoviral-mediated gene transfer of a kinase-inactive CaMKII mutant. Inhibition of CaMKII activation but not CaMKII autonomous activity significantly decreased formation of the CaMKII/ERK complex. On the contrary, the expression of constitutively active CaMKII enhanced VSMC growth and CaMKII/ERK association. In addressing the mechanism of this effect, we found that CaMKII could not directly phosphorylate ERK but instead enhanced Raf1 activation. By contrast, ERK interaction with CaMKII facilitated CaMKII phosphorylation and promoted its nuclear localization. Our results reveal a critical role for CaMKII in VSMC proliferation and imply that CaMKII facilitates assembly of the Raf/MEK/ERK complex and that ERK enhances CaMKII activation and influences its subcellular localization.

18 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Rosanna MallamaciRosanna Mallamaci
Rosanna Mallamaci
Roberta BudriesiRoberta Budriesi
Roberta Budriesi
maria clodoveomaria clodoveo
maria clodoveo
GBGiulia Biotti
Giulia Biotti
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
CFCarlo FRANCHINI
Carlo FRANCHINI
Extra-virgin olive oil (EVOO) contains many bioactive compounds with multiple biological activities that make it one of the most important functional foods. Both the constituents of the lipid fraction and that of the unsaponifiable fraction show a clear action in reducing oxidative stress by acting on various body components, at concentrations established by the European Food Safety Authority’s claims. In addition to the main product obtained by the mechanical pressing of the fruit, i.e., the EVOO, the residual by-products of the process also contain significant amounts of antioxidant molecules, thus potentially making the Olea europea L. an excellent example of the circular economy. In fact, the olive mill wastewaters, the leaves, the pomace, and the pits discharged from the EVOO production process are partially recycled in the nutraceutical and cosmeceutical fields also because of their antioxidant effect. This work presents an overview of the biological activities of these by-products, as shown by in vitro and in vivo assays, and also from clinical trials, as well as their main formulations currently available on the market.

2 October 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Anna CarusoAnna Caruso
Anna Caruso
ABAlexia Barbarossa
Alexia Barbarossa
ATAntonio Tassone
Antonio Tassone
Jessica CeramellaJessica Ceramella
Jessica Ceramella
ACAlessia Carocci
Alessia Carocci
Maria Stefania SinicropiMaria Stefania Sinicropi
Maria Stefania Sinicropi
Pomegranate is an old plant made up by flowers, roots, fruits and leaves, native to Central Asia and principally cultivated in the Mediterranean and California (although now widespread almost all over the globe). The current use of this precious plant regards not only the exteriority of the fruit (employed also for ornamental purpose) but especially the nutritional and, still potential, health benefits that come out from the various parts composing this one (carpellary membranes, arils, seeds and bark). Indeed, the phytochemical composition of the fruit abounds in compounds (flavonoids, ellagitannins, proanthocyanidins, mineral salts, vitamins, lipids, organic acids) presenting a significant biological and nutraceutical value. For these reasons, pomegranate interest is increased over the years as the object of study for many research groups, particularly in the pharmaceutical sector. Specifically, in-depth studies of its biological and functional properties and the research of new formulations could be applied to a wide spectrum of diseases including neoplastic, cardiovascular, viral, inflammatory, metabolic, microbial, intestinal, reproductive and skin diseases. In this review, considering the increasing scientific and commercial interest of nutraceuticals, we reported an update of the investigations concerning the health-promoting properties of pomegranate and its bioactive compounds against principal human pathologies.